This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Asahi Breweries, Ltd., Incorporated Administrative Agency National Agriculture and Food Research Organization. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2011
Title: Masanobu Kirita: Innovator in Methylated Catechin Synthesis
Introduction
Masanobu Kirita is a notable inventor based in Ibaraki, Japan. He has made significant contributions to the field of biotechnology, particularly in the synthesis of methylated catechins, which are known for their high antiallergic activity. His work has implications for various applications in health and wellness.
Latest Patents
Masanobu Kirita holds a patent for a gene encoding methylated catechin synthase. This gene is capable of effectively synthesizing methylated catechins that exhibit high antiallergic activity. The patent details that the gene contains at least one nucleotide sequence selected from the group consisting of SEQ ID NOs: 1, 3, and 5. This innovation represents a significant advancement in the field of functional foods and pharmaceuticals.
Career Highlights
Throughout his career, Masanobu Kirita has worked with prominent organizations, including Asahi Breweries, Ltd. and the National Agriculture and Food Research Organization. His experience in these institutions has allowed him to develop his expertise in biotechnology and contribute to various research initiatives.
Collaborations
Masanobu has collaborated with notable colleagues such as Manabu Sami and Mitsuo Ikeda. These partnerships have fostered a collaborative environment that enhances innovation and research in their respective fields.
Conclusion
Masanobu Kirita's contributions to the synthesis of methylated catechins highlight his role as an important inventor in biotechnology. His patent and collaborations reflect his commitment to advancing scientific knowledge and improving health outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile